Biogen (BIIB) Stock Price
$146.4 0.7%
to add to portfolio
AI Score
-
Alternative
3 -
Fundamental
8 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Biogen, AI stock picks, stock alerts and much more.
BIIB AI Stock Analysis
AI stock analysis for BIIB is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Biogen (BIIB) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Biogen (BIIB) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Biogen (BIIB), currently trading at $146.4, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About BIIB
-
Biogen Inc.
-
Symbol
BIIB
-
Market
NASDAQ
-
Industry
Drug Manufacturers - General
-
Market Cap
21.3B
Similar Stocks
 |
Astrazeneca AZN |
$70.24 0.9% |
5 |
 |
Amgen AMGN |
$281.8 0.5% |
6 |
 |
Gilead Sciences GILD |
$95.85 2.1% |
6 |
 |
Sanofi SNY |
$53.01 0.1% |
7 |
News
BIIB Alternative Data
Web Traffic
Biogen receives an estimated 149515 monthly visitors to biogen.com.
-
Web Traffic
149515
-
Change from Previous Month
12.4%
-
3 Month Change
29.7%
-
YoY Change
29.7%
News Mentions
Biogen was mentioned 4 times in the news yesterday.
-
News Mentions
4
-
Daily Change
50%
-
1 Month Change
33.3%
-
3 Month Change
50%
Twitter Followers
Biogen has 45,293 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.4% over the last month.
-
Twitter Followers
45293
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
1.1%
-
YoY Change
1.1%
Facebook Engagement
Biogen has engaged 191 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
191
-
Daily Change
2.6%
-
1 Month Change
69.4%
-
3 Month Change
93.5%
-
YoY Change
93.5%
Youtube Subscribers
Biogen has 9,960 subscribers on its main Youtube channel, up by 0.9% over the last month.
-
Youtube Subscribers
9960
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
3%
-
YoY Change
3%
LinkedIn Followers
1,069,098 are following Biogen on LinkedIn, up by 1.2% over the last month.
-
LinkedIn Followers
1069098
-
Daily Change
0%
-
1 Month Change
1.2%
-
3 Month Change
2.9%
Job Postings
Biogen currenly has an estimated 173 open job postings, up by 28.1% over the last month.
-
Job Postings
173
-
Daily Change
4.2%
-
1 Month Change
28.1%
-
3 Month Change
39.3%
-
YoY Change
39.3%
LinkedIn Employees
According to LinkedIn, Biogen has 7,799 employees, down by -2.8% over the last month.
-
LinkedIn Employees
7799
-
Daily Change
0%
-
1 Month Change
2.8%
-
3 Month Change
3.8%
-
YoY Change
3.8%
Business Outlook
-
Business Outlook
40
-
Change from Previous Month
4.8%
-
3 Month Change
0%
-
YoY Change
0%
BIIB Financials
BIIB Key Metrics
-
Total Revenue
$2.5B
-
Net Income
$388.5M
-
Earnings per Share
$2.67
-
Free cash flow
$1.2B
-
EBITDA
$451M
-
EBITDA Ratio
0.182902
-
Total Assets
$28.3B
BIIB 2-year Revenue & Income
BIIB 2-year Free Cash Flow
BIIB Technicals
BIIB SMA
BIIB RSI
FAQ
What's the current price of Biogen (BIIB) Stock?
The price of an Biogen (BIIB) share is $146.4.
What's the market cap of Biogen?
The current market cap of Biogen is 21.3B.
Should I buy or sell BIIB?
Biogen shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Biogen is better viewed as a hold or accumulate position while waiting for further developments.
Is Biogen a good investment?
The current analysis of Biogen's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Biogen's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Biogen (BIIB) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Biogen stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Biogen (BIIB) that investors often compare it to?
Biogen (BIIB) is often compared to similar stocks such as Astrazeneca, Amgen, Gilead Sciences and Sanofi.
What is the forecast for Biogen's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Biogen's stock price to be around $141.6 in 2026. Starting from the current price of $146.4, this represents a 3.3% change in price, indicating a neutral outlook for the stock.
How to buy Biogen (BIIB) Stock?
Biogen stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Biogen shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.